CDKN2A and breast carcinoma: In a study conducted in 2018 by ShahidSales et al. On the association of rs10811661 polymorphism in CDKN2A / B in healthy and breast cancer patients, they concluded that the frequency of TT genotype was higher in breast cancer patients than in the control group.